Senthamil Selvan P, Gowda K Veeran, Mandal U, Sam Solomon W D, Pal T K
Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):269-75. doi: 10.1016/j.jchromb.2007.09.002. Epub 2007 Sep 14.
A rapid, sensitive and accurate liquid chromatographic-tandem mass spectrometry (LC-MS-MS) method is described for the determination of duloxetine in human plasma. Duloxetine was extracted from plasma using methanol and separated on a C18 column. The mobile phase consisting of a mixture of acetonitrile and 5mM ammonium acetate (45:55, v/v, pH 3.5) was delivered at a flow rate of 0.3 ml/min. Atmospheric pressure ionization (API) source was operated in positive ion mode. Multiple reaction monitoring (MRM) mode using the transitions of m/z 298.1-->m/z 44.0 and m/z 376.2-->m/z 123.2 were used to quantify duloxetine and internal standard (I.S.), respectively. The linearity was obtained over the concentration range of 0.1-50.0 ng/ml and the lower limit of quantitation (LLOQ) was 0.1 ng/ml. This method was successfully applied to pharmacokinetic study of a duloxetine formulation product after oral administration to healthy human subjects.
本文描述了一种快速、灵敏且准确的液相色谱-串联质谱法(LC-MS-MS),用于测定人血浆中的度洛西汀。度洛西汀采用甲醇从血浆中萃取,并在C18柱上进行分离。流动相由乙腈和5mM醋酸铵(45:55,v/v,pH 3.5)的混合物组成,以0.3 ml/min的流速输送。大气压电离(API)源在正离子模式下运行。采用m/z 298.1→m/z 44.0和m/z 376.2→m/z 123.2的跃迁分别对度洛西汀和内标(I.S.)进行多反应监测(MRM)模式定量。在0.1 - 50.0 ng/ml的浓度范围内获得线性关系,定量下限(LLOQ)为0.1 ng/ml。该方法成功应用于度洛西汀制剂产品口服给药于健康人体受试者后的药代动力学研究。